Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.

ABSTRACT:

Importance

The federal 340B program lowers the acquisition cost of prescription drugs and places no limits on what hospitals charge payers. Congress established the program to allow 340B profits (the difference between payments and acquisition costs) to subsidize other safety-net services. Little is known about the magnitude of revenues and profits from the 340B program among participating hospitals.

Objective

To report revenues and estimated profits from the 340B program that hospitals collect from Medicare and Medicare beneficiaries for outpatient clinic administration of prescription drugs covered under Medicare Part B.

Design, setting, and participants

This cross-sectional descriptive study used 100% Medicare outpatient Part B claims from January 1, 2013, to Decem

SUBMITTER: Conti RM 

PROVIDER: S-EPMC6824218 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature